Side Effects of Drugs Annual

Side Effects of Drugs Annual

A worldwide yearly survey of new data in adverse drug reactions

1st Edition - March 1, 2013

Write a review

  • Editor: Jeffrey Aronson
  • eBook ISBN: 9780444626363
  • Hardcover ISBN: 9780444626356

Purchase options

Purchase options
DRM-free (Mobi, EPub, PDF)
Available
Sales tax will be calculated at check-out

Institutional Subscription

Free Global Shipping
No minimum order

Description

The Side Effects of Drugs Annual was first published in 1977. It has been continually published since then as a yearly update to the voluminous encyclopedia, Meyler's Side Effects of Drugs. Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of adverse drug reactions and interactions. An international team of specialists has contributed to the informative Annual by critically interpreting it and by pointing to whatever is misleading.

Key Features

  • Provides a critical yearly survey of new data and trends
  • Special reviews in this Annual include, among other topics, epidemiology of the use of ecstasy, paracetamol and the risk of asthma, combination vaccines/multiple immunizations, interactions of herbal medicines with warfarin, and tyrosine kinase inhibitors

Readership

Pharmacologists, clinicians, pharmaceutical companies, clinical toxicologists, clinical pharmacologists and medical libraries

Table of Contents

  • Contributors
    Special reviews in SEDA-35
    Cumulative indexes of special reviews, Annuals 4–34
    1 Index of medications in special reviews

    2 Index of adverse effects and adverse reactions in special reviews

    Table of Essays, Annuals 1–34
    Mechanistic and clinical descriptions of adverse drug reactions
    1 EIDOS

    2 DoTS

    Definitive (between-the-eyes) adverse drug reactions
    How to use this book
    The scope of the Side Effects of Drugs Annuals

    Period covered

    Selection of material

    Allocation of drugs to chapters

    Names of drugs and chemicals

    System of tagging references

    Indexes

    Abbreviations
    35 years of the Side Effects of Drugs Annuals—a tribute to our contributors
    Classification of immunological reactions
    Classification of drug teratogenicity
    Grades of adverse drug reactions
    Side effects of drugs essay
    Abstract

    Chapter 1: Central nervous system stimulants and drugs that suppress appetite
    Abstract

    Amphetamines [SED-15, 180; SEDA-32, 1; SEDA-33, 1; SEDA-34, 1]

    Methylxanthines

    Drugs That Suppress Appetite [SEDA-32, 16; SEDA-33, 13; SEDA-34, 8]

    Drugs Used in Alzheimer’s Disease [SEDA-32, 19; SEDA-33, 15; SEDA-34, 9]

    Chapter 2: Antidepressant drugs
    Abstract

    General

    Selective Serotonin Re-uptake Inhibitors (SSRIs) [SED-15, 3109; SEDA-32, 33; SEDA-33, 26; SEDA-34, 37]

    Serotonin and Noradrenaline Re-uptake Inhibitors (SNRIs)

    Tricyclic Antidepressants

    Monoamine Oxidase Inhibitors

    Other Antidepressants

    Chapter 3: Lithium
    Abstract

    Chapter 4: Drugs of abuse
    Abstract

    Cannabinoids [SED-15, 614; SEDA-32, 55; SEDA-33, 55; SEDA-34, 33]

    Opioid Analgesics

    Chapter 5: Hypnosedatives and anxiolytics
    Abstract

    Azaspirones [SEDA-32, 75; SEDA-33, 71; SEDA-34, 45]

    Benzodiazepines [SED-15, 429; SEDA-32, 75; SEDA-33, 45]

    Benzodiazepine-Like Drugs

    Benzodiazepine Antagonists

    Other Hypnosedatives

    Chapter 6: Antipsychotic drugs
    Abstract

    General [SED-15, 2438; SEDA-32, 83; SEDA-33, 89; SEDA-34, 51]

    Individual Drugs

    Chapter 7: Antiepileptic drugs
    Abstract

    Chapter 8: Opioid analgesics and narcotic antagonists
    Abstract

    General

    Opioid Receptor Agonists

    Partial Opioid Receptor Agonists

    Opioid Receptor Antagonists

    Chapter 9: Anti-inflammatory and antipyretic analgesics and drugs used in gout
    Abstract

    Amidopyrine and Related Compounds

    Aniline Derivatives [SED-15, 2679; SEDA-33, 244; SEDA-34, 184]

    Non-steroidal Anti-inflammatory Drugs

    Anthranilic Acid Derivatives

    Arylalkanoic Acid Derivatives [SED-15, 2555; SEDA-32, 229; SEDA-33, 245; SEDA-34, 185]

    COX-2 Selective Inhibitors [SEDA-32, 232; SEDA-33, 246; SEDA-34, 186]

    Oxicams [SEDA-15, 2555; SEDA-32, 233; SEDA-33, 247; SEDA-34, 187]

    Pyrazolone Derivatives (Phenylbutazone and Related Compounds) [SEDA-27, 111]

    Salicylates [SED-15, 15; SEDA-33, 248; SEDA-34, 188]

    Miscellaneous Drugs

    Drugs Used in the Treatment of Gout

    Chapter 10: General anesthetics and therapeutic gases
    Abstract

    Anesthetic Vapors [SEDA-32, 243; SEDA-33, 257; SEDA-34, 195]

    Other Vapors

    Intravenous Agents: Non-barbiturate Anesthetics

    Intravenous Agents: Barbiturate Anesthetics

    Chapter 11: Local anesthetics
    Abstract

    General

    Effects Related to Modes of Use [SED-15, 2121; SEDA-32, 262; SEDA-33, 281; SEDA-34, 209]

    Caudal, Epidural, and Spinal Anesthesia

    Individual Compounds

    Chapter 12: Neuromuscular blocking agents and skeletal muscle relaxants
    Abstract

    Depolarizing Neuromuscular Blocking Agents

    Non-depolarizing Neuromuscular Blocking Agents [SED-15, 2489; SEDA-32, 274; SEDA-33, 301; SEDA-34, 222]

    Skeletal Muscle Relaxants

    Chapter 13: Drugs that affect autonomic functions or the extrapyramidal system
    Abstract

    Drugs That Stimulate Both Alpha- and Beta-Adrenoceptors [SEDA-32, 281; SEDA-33, 313; SEDA-34, 233]

    Drugs That Predominantly Stimulate Alpha1-Adrenoceptors [SEDA-32, 283; SEDA-33, 318; SEDA-34, 236]

    Drugs That Stimulate Beta1-Adrenoceptors [SEDA-32, 284; SEDA-33, 265; SEDA-34, 240]

    Drugs That Stimulate Beta2-Adrenoceptors [SEDA-34, 241]

    Drugs That Stimulate Dopamine Receptors [SEDA-33, 266; SEDA-34, 342]

    Drugs That Stimulate Dopamine Receptors

    Other Drugs That Increase Dopamine Activity

    Drugs That Affect the Cholinergic System [SEDA-32, 290; SEDA-33, 324; SEDA-34, 246]

    Chapter 14: Dermatological drugs, topical agents, and cosmetics
    Abstract

    Cosmetics

    Dermal Fillers

    Dyestuffs [SEDA-15, 1573; SEDA-32, 296]

    Fragrances

    Glucocorticoids, Topical

    Phototherapy and Photochemotherapy [SED-15, 2823; SEDA-32, 297; SEDA-34, 262]

    Sunscreens [SED-15, 3248; SEDA-34, 263]

    Vitamin A (Retinoids) [SED-15, 3653; SEDA-32, 298; SEDA-34, 264; for vitamin A carotenoids see Chapter 34]

    Vitamin D Analogues, Topical [SED-15, 594; SEDA-32, 301; SEDA-34, 265; for oral Vitamin D analogues see Chapter 34]

    Devices

    Chapter 15: Antihistamines (H1 receptor antagonists)
    Abstract

    General

    Other Antihistamines

    Chapter 16: Drugs that act on the respiratory tract
    Abstract

    Inhaled Glucocorticoids [SEDA -32, 311; SEDA -33, 353; SEDA -34, 277]

    Nasal Glucocorticoids [SEDA -34, 279]

    Beta2-Adrenoceptor Agonists [SEDA -32, 314; SEDA -33, 357; SEDA -34, 280]

    Anticholinergic Drugs [SEDA -32, 318; SEDA -33, 363; SEDA -34, 282]

    Leukotriene Modifiers [SEDA -32, 319; SEDA -33, 366; SEDA -34, 283]

    Phosphodiesterase Type IV Inhibitors [SEDA -32, 321; SEDA -33, 367; SEDA -34, 284]

    Mucolytic Drugs [SEDA -32, 325; SEDA -33, 369]

    Antitussive Drugs

    Chapter 17: Positive inotropic drugs and drugs used in dysrhythmias
    Abstract

    Cardiac Glycosides [SED-15, 648; SEDA-32, 333; SEDA-33, 377; SEDA-34, 287]

    Other Positive Inotropic Drugs [SED-15, 2822; SEDA-31, 323; SEDA-32, 336; SEDA-33, 378]

    Antidysrhythmic Drugs

    Adenosine Receptor Agonists [SEDA-32, 337; SEDA-33, 379; SEDA-34, 292]

    Chapter 18: Beta-adrenoceptor antagonists and antianginal drugs
    Abstract

    Beta-Adrenoceptor Antagonists [SED-15, 452; SEDA-32, 363; SEDA-33, 397; SEDA-34, 303]

    Potassium Channel Activators

    Nitrates, Organic [SED-15, 2529; SEDA-32, 366; SEDA-33, 400; SEDA-34, 305]

    Calcium Channel Blockers [SED-15, 598; SEDA-32, 366; SEDA-33, 401; SEDA-34, 306]

    Chapter 19: Drugs acting on the cerebral and peripheral circulations
    Abstract

    Drugs Used in the Treatment of Arterial Disorders of the Brain and Limbs

    Drugs Used in the Treatment of Venous Disorders

    Drugs Used in the Treatment of Migraine

    Other Peripheral Vasodilators

    Chapter 20: Antihypertensive drugs
    Abstract

    General

    Angiotensin Converting Enzyme (ACE) Inhibitors [SED-15, 226; SEDA -32, 379; SEDA -33, 416; SEDA-34, 321]

    Angiotensin II Receptor Antagonists [SED-15, 223; SEDA-32, 387; SEDA-33, 418; SEDA-34, 325]

    Dual Angiotensin II Receptor Antagonists/Neprilysin Antagonists

    Direct Renin Inhibitors [SEDA-32, 388; SEDA-33, 420; SEDA-34, 328]

    Endothelin Receptor Antagonists [SED-15, 1215; SEDA-32, 389; SEDA-33, 421; SEDA-34, 328]

    Drugs That Act on the Sympathetic Nervous System [SEDA-32, 391; SEDA-33, 424; SEDA-34, 329]

    Non-selective α-Adrenoceptor Antagonists

    Postsynaptic α-Adrenoceptor Antagonists [SEDA-32, 391; SEDA-33, 425; SEDA-34, 330]

    Imidazoline Receptor Agonists

    Direct Vasodilators

    Chapter 21: Diuretics
    Abstract

    Carbonic Anhydrase Inhibitors [SED-15, 643; SEDA-32, 403; SEDA-33, 437; SEDA-34, 339]

    Thiazide and Thiazide-Like Diuretics [SED-15, 3375; SEDA-32, 405; SEDA-33, 438; SEDA-34, 340]

    Loop Diuretics [SED-15, 567, 1454; SEDA-32, 408; SEDA-33, 440; SEDA-34, 342]

    Aldosterone Receptor Antagonists

    Osmotic Diuretics

    Chapter 22: Metals
    Abstract

    Chapter 23: Metal antagonists
    Abstract

    Iron Chelators

    Penicillamine and Related Drugs [SED-15, 2729; SEDA-32, 430; SEDA-33, 472; SEDA-34, 372]

    Other Chelators

    Polystyrene Sulfonates [SED-15, 2894; SEDA-32, 433; SEDA-33, 474; SEDA-34, 373]

    Chapter 24: Antiseptic drugs and disinfectants
    Abstract

    Aldehydes [SED-15, 1439, 1513; SEDA-32, 437; SEDA-33, 479; SEDA-34, 377]

    Bisbiguanides

    Boric Acid

    Cationic Surfactants

    Halogens

    Iodophors [SED-15, 1896; SEDA-32, 440; SEDA-33, 485; SEDA-34, 380]

    Phenols [SED-15, 2800, SEDA-32, 441; SEDA-33, 485; SEDA-34, 381]

    Chapter 25: Penicillins, cephalosporins, other beta-lactam antibiotics, and tetracyclines
    Abstract

    Beta-Lactam Antibiotics [SED-15, 478; SEDA-32, 447; SEDA-33, 491; SEDA-34, 385]

    Cephalosporins [SED-15, 688; SEDA-32, 448; SEDA-33, 493; SEDA-34, 386]

    Monobactams and Monocarbams [SED-15, 2378; SEDA-32, 450; SEDA-33, 494; SEDA-34, 388]

    Penicillins [SED-15, 2756; SEDA-32, 450; SEDA-33, 495; SEDA-34, 388]

    Tetracyclines and Glycylcyclines [SED-15, 3330; SEDA-32, 451; SEDA-33, 497; SEDA-34, 391]

    Chapter 26: Miscellaneous antibacterial drugs
    Abstract

    Aminoglycosides [SED-15, 118; SEDA-32, 461; SEDA-33, 509; SEDA-34, 399]

    Fluoroquinolones [SED-15, 1396; SEDA-32, 464; SEDA-33, 514; SEDA-34, 401]

    Glycopeptides [SEDA-32, 469; SEDA-33, 519; SEDA-34, 405]

    Ketolides [SED-15, 1976; SEDA-32, 471; SEDA-33, 521; SEDA-34, 407]

    Lincosamides [SED-15, 2063; SEDA-32, 472; SEDA-33, 522; SEDA-34, 407]

    Macrolides [SED-15, 2183; SEDA-32, 472; SEDA-33, 522; SEDA-34, 408]

    Nitrofurantoin [SED-15, 2542; SEDA-32, 476, SEDA-33, 525; SEDA-34, 409]

    Oxazolidinones [SED-15, 2645; SEDA-32, 474; SEDA-33, 525; SEDA-34, 409]

    Polymyxins [SED-15, 2891; SEDA-32, 476; SEDA-33, 527; SEDA-34, 412]

    Streptogramins [SED-15, 3182; SEDA-32, 528; SEDA-34, 413]

    Sulfonamides, Trimethoprim, and Co-trimoxazole [SED-15, 3216, 3510; SEDA-32, 477; SEDA-33, 528; SEDA-34, 414]

    Other Antimicrobial Drugs

    Chapter 27: Antifungal drugs
    Abstract

    Allylamines [SEDA -32, 491; SEDA -33, 541; SEDA -34, 427]

    Amphotericin [SED -15, 192; SEDA -32, 493; SEDA -33, 542; SEDA -34, 427]

    Antifungal Azoles [SED -15, 301; SEDA -32, 497; SEDA -33, 545; SEDA -34, 428]

    Echinocandins [SED -15, 1197; SEDA -32, 507; SEDA -33, 556; SEDA -34, 434]

    Chapter 28: Antiprotozoal drugs
    Abstract

    Antimalarial Drugs

    4-Aminoquinolines (Chloroquine and Congeners) [SEDA-32, 521; SEDA-33, 567; SEDA-34, 441]

    Pyrimethamine and Combinations [SED-15, 2984; SEDA-32, 523; SEDA-33, 570]

    Primaquine and Congeners [SED-15, 2919; SEDA-33, 569; SEDA-34, 442]

    Quinine and Congeners [SED-15, 3002; SEDA-32, 524; SEDA-33, 570]

    Endoperoxides [SED-15, 342; SEDA-32, 525; SEDA-33, 571; SEDA-34, 442]

    Drugs Used in the Treatment of Other Protozoal Infections

    Chapter 29: Antiviral drugs
    Abstract

    Drugs Active Against Cytomegalovirus

    Drugs Active Against Herpesviruses [SEDA-32, 530; SEDA-33, 577; SEDA-34, 450]

    Drugs Active Against Hepatitis Viruses

    Direct-Acting Antiviral Protease Inhibitors

    Drugs Active Against Human Immunodeficiency Virus: Combinations

    Drugs Active Against Human Immunodeficiency Virus: Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTI) [SED-15, 2586; SEDA-32, 534; SEDA-33, 585; SEDA-34, 456]

    Drugs Active Against Human Immunodeficiency Virus: Nucleotide Analogue Reverse Transcriptase Inhibitors

    Drugs Active Against Human Immunodeficiency Virus: Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI) [SED-15, 2553; SEDA-32, 537; SEDA-33, 590; SEDA-34, 459]

    Drugs Active Against Human Immunodeficiency Virus: Protease Inhibitors [SED-15, 2586; SEDA-32, 541; SEDA-33, 593; SEDA-34, 461]

    Drugs Active Against Human Immunodeficiency Virus: Inhibitors of HIV Fusion [SEDA-33; 598; SEDA-34, 464]

    Drugs Active Against Human Immunodeficiency Virus: Integrase Inhibitors [SEDA-33, 599; SEDA-34, 465]

    Drugs Active Against Human Immunodeficiency Virus: Chemokine Receptor CCR5 Antagonists [SEDA-33, 600; SEDA-34, 465]

    Drugs Active Against Influenza Viruses: Neuraminidase Inhibitors [SED-15, 2436; SEDA-32, 544; SEDA-33, 601; SEDA-34, 466]

    Drugs Active Against Influenza Viruses: Ion Channel Inhibitors [SED-15, 105, 3051; SEDA-32, 544; SEDA-33, 269, 602; SEDA-34, 467]

    Other Drugs

    Chapter 30: Drugs used in tuberculosis and leprosy
    Abstract

    Rifamycins [SED-15, 3040; SEDA-32, 563; SEDA-33, 637; SEDA-34, 484]

    Chapter 31: Antihelminthic drugs
    Abstract

    Benzimidazoles [SED -15, 424; SEDA -32, 572; SEDA -33, 647; SEDA -34, 487]

    Chapter 32: Vaccines
    Abstract

    General

    Bacterial Vaccines

    Viral Vaccines

    Measles, Mumps, and Rubella Vaccines

    Other Components of Vaccines

    Chapter 33: Blood, blood components, plasma, and plasma products
    Abstract

    Albumin and Derivatives [SED-15, 54; SEDA-32, 591; SEDA-33, 670; SEDA-34, 509]

    Blood Transfusion [SED-15, 529; SEDA-32, 593; SEDA-33, 671; SEDA-34, 509]

    Blood Substitutes [SEDA-32, 593; SEDA-33, 672; SEDA-34, 511]

    Plasma and Plasma Products [SED-15, 2847; SEDA-32, 594; SEDA-33, 674; SEDA-34, 512]

    Plasma Substitutes [SEDA-32, 594; SEDA-33, 675; SEDA-34, 513]

    Globulins

    Coagulation Proteins [SED-15, 845; SEDA-32, 596; SEDA-33, 679; SEDA-34, 518]

    Erythropoietin and Derivatives [SED-15, 1243; SEDA-32, 597; SEDA-33, 681; SEDA-34, 520]

    Stem Cells [SEDA-32, 599; SEDA-33, 682; SEDA-34, 522]

    Chapter 34: Vitamins, amino acids, and drugs and formulations used in nutrition
    Abstract

    Vitamin A (Carotenoids) [SED-15, 3642; SEDA-32, 607; SEDA-33, 691; SEDA-34, 531]

    Vitamins of the B Group [SED-15, 1432, 3668; SEDA-32, 608; SEDA-33, 693; SEDA-34, 531]

    Vitamin C (Ascorbic Acid) [SED-15, 351; SEDA-32, 611; SEDA-33, 694; SEDA-34, 531]

    Vitamin D Analogues [SED-15, 3669; SEDA-32, 612; SEDA-33, 695; SEDA-34, 532]

    Vitamin E (Tocopherol) [SED-15, 3677; SEDA-32, 612; SEDA-33, 696; SEDA-34, 533]

    Vitamin K Analogues [SED-15, 3681; SEDA-34, 533]

    Amino Acids

    Enteral and Parenteral Nutrition [SED-15, 1221, 2700; SEDA-32, 613; SEDA-33, 697; SEDA-34, 536]

    Chapter 35: Drugs that affect blood coagulation, fibrinolysis, and hemostasis
    Abstract

    Coumarin Anticoagulants [SED-15, 983; SEDA-32, 617; SEDA-33, 707; SEDA-34, 541]

    Heparins [SED-15, 1590; SEDA-32, 626; SEDA-33, 713; SEDA-34, 543]

    Direct Thrombin Inhibitors [SED-15, 1142; -32, 632; SEDA-33, 717; SEDA-34, 544]

    Direct Factor Xa Inhibitors [SEDA-32, 635; SEDA-34, 546]

    Indirect Factor Xa Inhibitors [SEDA-32, 636; SEDA-33, 636; SEDA-34, 547]

    Thrombolytic Drugs [SED-15, 3402]

    Drugs that Alter Platelet Function [SEDA-32, 637; SEDA-33, 637; SEDA-34, 547]

    Glycoprotein IIb-IIIa Inhibitors [SED-15, 4; SEDA-32, 638; SEDA-33, 720; SEDA-34, 548]

    Thienopyridines [SED-15, 821; SEDA-32, 639; SEDA-33, 720; SEDA-34, 548]

    Hemostatic Agents

    Chapter 36: Gastrointestinal drugs
    Abstract

    Antacids [SED-15, 243; SEDA-32, 665; SEDA-33, 741; SEDA-34, 555]

    Antiemetics and Drugs That Affect Gastrointestinal Motility [SEDA-32, 665; SEDA-33, 741; SEDA-34, 555]

    5HT3 Receptor Antagonists [SED-15, 1365; SEDA-32, 666; SEDA-33, 744; SEDA-34, 559]

    Neurokinin NK1 Receptor Antagonists [SEDA-32, 667; SEDA-33, 748; SEDA-34, 561]

    Histamine H2 Receptor Antagonists [SED-15, 1629; SEDA-32, 667; SEDA-33, 748; SEDA-34, 562]

    Proton Pump Inhibitors [SED-15, 2973; SEDA-32, 667; SEDA-33, 749; SEDA-34, 563]

    Helicobacter Pylori Eradication Regimens [SEDA-33, 749]

    Other Ulcer-Healing Agents

    Cholelitholytic Agents

    Laxatives and Oral Bowel Preparations [SED-15, 2008; SEDA-32, 668; SEDA-33, 753; SEDA-34, 569]

    Bowel Secretagogues

    Aminosalicylates [SED-15, 138; SEDA-32, 669; SEDA-33, 756; SEDA-34, 571]

    Antispasmodic Agents

    Antidiarrheal Agents

    Probiotics

    Other Gastrointestinal Agents

    Chapter 37: Drugs that act on the immune system: cytokines and monoclonal antibodies
    Abstract

    Colony-Stimulating Factors [SEDA-32, 675; SEDA-33, 769; SEDA-34, 581]

    Interferons [SED-15, 1841; SEDA-32, 676; SEDA-33, 773; SEDA-34, 581]

    Interleukins [SED-15, 1831; SEDA-32, 676; SEDA-33, 777; SEDA-33, 771]

    Tumor Necrosis Factor Alfa (TNF-α) and Its Antagonists [SEDA-32, 677; SEDA-33, 779; SEDA-34, 583]

    VEGF Antagonists

    Monoclonal Antibodies [SED-15, 2380; SEDA-32, 686; SEDA-33, 783; SEDA-34, 586]

    Chapter 38: Drugs that act on the immune system: immunosuppressive and immunostimulatory drugs
    Abstract

    Thiopurines [SED-15, 377; SEDA-32, 717; SEDA-33, 824; SEDA-34, 633]

    Immunoenhancing Drugs

    Chapter 39: Corticotrophins, corticosteroids, and prostaglandins
    Abstract

    Corticotrophins [SED-15, 906; SEDA-32, 723; SEDA-33, 841; SEDA-34, 653]

    Systemic Glucocorticoids [SED-15, 906; SEDA-32, 723; SEDA-33, 841; SEDA-34, 653]

    Prostaglandins and Analogues [SED-15, 2955; SEDA-31 SEDA-32, 729; SEDA-33, 846; SEDA-34, 660]

    Chapter 40: Sex hormones and related compounds, including hormonal contraceptives
    Abstract

    Estrogens [SED-15, 1253; SEDA-32, 736; SEDA-33, 852; SEDA-34, 663]

    Hormonal Contraceptives [SED-15, 1642; SEDA-32, 741; SEDA-33, 858; SEDA-34, 667]

    Antiestrogens and Selective Estrogen Receptor Modulators (SERMs) [SEDA-32, 743; SEDA-33, 859; SEDA-34, 669]

    Progestogens [SED-15, 2930; SEDA-32, 747; SEDA-33, 865; SEDA-34, 671]

    Progesterone Antagonists [SEDA-32, 749; SEDA-33, 866; SEDA-34, 671]

    Anabolic Steroids, Androgens, and Related Compounds [SED-15, 216; SEDA-32, 751; SEDA-33, 868; SEDA-34, 672]

    Antiandrogens [SEDA-32, 755; SEDA-33, 872; SEDA-34, 674]

    Chapter 41: Thyroid hormones, iodine and iodides, and antithyroid drugs
    Abstract

    Thyroid Hormones [SED-15, 3409; SEDA-32, 763; SEDA-33, 881; SEDA-34, 679]

    Iodine and Iodides [SED-15, 1896; SEDA-32, 764; SEDA-33, 883; SEDA-34, 680]

    Antithyroid Drugs [SED-15, 3387; SEDA-32, 765; SEDA-33, 884; SEDA-34, 681]

    Chapter 42: Insulin, other hypoglycemic drugs, and glucagon
    Abstract

    Glucagon [SED-15, 1510; SEDA-32, 769; SEDA-33, 889]

    Insulin [SED-15, 1761; SEDA-32, 769; SEDA-33, 889; SEDA-34, 685]

    Alpha Glucosidase Inhibitors [SEDA-32, 772 SEDA-33, 893]

    Amylin Analogues [SEDA-32, 773; SEDA-33, 893; SEDA-34, 687]

    Biguanides [SED-15, 506; SEDA-32, 773; SEDA-33, 893; SEDA-34, 687]

    Dipeptidyl Peptidase 4 (DDP-4) Inhibitors [SEDA-32, 774; SEDA-33, 894; SEDA-34, 688]

    Incretin Mimetics [SEDA-32, 775; SEDA-33, 896; SEDA-34, 690]

    Meglitinides [SED-15, 2238; SEDA-32, 776; SEDA-33, 897; SEDA-34, 694]

    Sodium–Glucose Transporter Type 2 (SGLT2) Inhibitors [SEDA-33, 898; SEDA-34, 695]

    Sulfonylureas [SED-15, 3230; SEDA-32, 777; SEDA-33, 898; SEDA-34, 695]

    Thiazolidinediones (Glitazones) [SED-15, 3380; SEDA-32, 779; SEDA-33, 899; SEDA-34, 696]

    Peroxisome Proliferator-Activated Receptor Partial Agonists

    Peroxisome Proliferator-Activated Dual Receptor Agonists [SEDA-32, 782; SEDA-33, 902; SEDA-34, 698]

    Chapter 43: Corticotrophins, corticosteroids, and prostaglandins
    Abstract

    Vasopressin Receptor Antagonists [SEDA-34, 713]

    Vasopressin and Analogues [SED-15, 3609; SEDA-32, 798; SEDA-33, 915; SEDA-34, 714]

    Chapter 44: Drugs that affect lipid metabolism
    Abstract

    Bile Acid Sequestrants [SED -15, 1902]

    Cholesteryl Ester Transfer Protein Inhibitors [SEDA -32, 817; SEDA -33, 929; SEDA -34, 723]

    Fibrates [SED -15, 1358; SEDA -32, 804; SEDA -33, 922; SEDA -34,724]

    HMG-CoA Reductase Inhibitors [SED -15, 1632; SEDA -32, 807; SEDA -33, 924; SEDA -34, 725]

    Nicotinic Acid Derivatives [SED -15, 2512; SEDA -32, 815; SEDA -33, 928; SEDA -34, 728]

    Chapter 45: Cytostatic and cytotoxic drugs
    Abstract

    Chapter 46: Radiological contrast agents and radiopharmaceuticals
    Abstract

    MRI contrast media

    Ultrasound contrast agents [SED-15, 3543; SEDA-32, 855; SEDA-33, 971; SEDA-34, 758]

    Radiopharmaceuticals [SED-15, 3017; SEDA-33, 973; SEDA-34, 758]

    Chapter 47: Drugs used in ocular treatment
    Abstract

    Drugs Used in the Management of Macular Degeneration [SEDA-32, 865; SEDA-33, 977; SEDA-34, 761]

    Adrenoceptor Agonists [SEDA-32, 869; SEDA-33, 982; SEDA-34, 762]

    Alpha-Adrenoceptor Agonists

    Antibacterial Drugs

    Anticholinergic Drugs [SEDA-34, 763]

    Beta-Adrenoceptor Antagonists

    Carbonic Anhydrase Inhibitors

    Glucocorticosteroids [SED-15, 906; SEDA-32, 871; SEDA-33, 983; SEDA-34, 764]

    Non-steroidal Anti-inflammatory Drugs [SEDA-34, 764]

    Prostaglandin Analogues [SEDA-32, 871; SEDA-33, 984; SEDA-34, 764]

    Devices and Procedures

    Chapter 48: Treatments used in complementary and alternative medicine
    Abstract

    Asian Herbal Medicines [SED-15, 1609; SEDA-32, 879]

    Nutritional Supplements

    Specific Plants

    Acupuncture

    Chiropractic

    Moxibustion

    Chapter 49: Miscellaneous drugs, materials, medical devices, and techniques
    Abstract

    Dyestuffs [SEDA-32, 895; SEDA-33, 1016; SEDA-34, 791]

    Sclerosants [SED-15, 3107; SEDA-33, 1021; SEDA-34, 795]

    Index of drugs
    Index of drug-drug interactions
    Index of adverse effects and adverse reactions

Product details

  • No. of pages: 1056
  • Language: English
  • Copyright: © Elsevier 2014
  • Published: March 1, 2013
  • Imprint: Elsevier
  • eBook ISBN: 9780444626363
  • Hardcover ISBN: 9780444626356

About the Editor

Jeffrey Aronson

Affiliations and Expertise

Reader in Clinical Pharmacology

Ratings and Reviews

Write a review

There are currently no reviews for "Side Effects of Drugs Annual"